{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:00:13Z","timestamp":1791342013245,"version":"4.3.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.ajog.2004.05.068","type":"journal-article","created":{"date-parts":[[2004,10,23]],"date-time":"2004-10-23T23:05:56Z","timestamp":1098572756000},"page":"1452-1458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":220,"title":["Association of extreme first-trimester free human chorionic gonadotropin-\u03b2, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes"],"prefix":"10.1016","volume":"191","author":[{"given":"David","family":"Krantz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Goetzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe Leigh","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Thom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Zachary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence W.","family":"Hallahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Pergament","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence D.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Filkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Allen","family":"Hogge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Douglas","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mohide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Hershey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Wapner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2004.05.068_bib1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0029-7844(97)00151-8","article-title":"Prediction of adverse perinatal outcome by maternal serum screening for Down syndrome in an Asian population","volume":"89","author":"Hsieh","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.05.068_bib2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0002-9378(99)70334-0","article-title":"Second-trimester maternal serum marker screening: maternal serum \u03b1-fetoprotein, \u03b2-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome","volume":"181","author":"Yaron","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.05.068_bib3","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJMoa025273","article-title":"First trimester screening for trisomies 21 and 18","volume":"349","author":"Wapner","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2004.05.068_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1469-0705.2002.00808.x","article-title":"One-stop clinic for assessment for risk for trisomy 21 at 11-14 weeks: a prospective study of 15,030 pregnancies","volume":"20","author":"Bindra","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.05.068_bib5","first-page":"207","article-title":"First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency","volume":"96","author":"Krantz","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.05.068_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/A:1022381506823","article-title":"1994-1996 U.S. singleton birth weight percentiles for gestational age by race, Hispanic origin, and gender","volume":"3","author":"Alexander","year":"1999","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.ajog.2004.05.068_bib7","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1471-0528.2000.tb11618.x","article-title":"First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications","volume":"107","author":"Ong","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2004.05.068_bib8","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/pd.735","article-title":"Predicting complications of pregnancy with first-trimester maternal serum free beta hCG, PAPP-A and inhibin A","volume":"23","author":"Tul","year":"2003","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2004.05.068_bib9","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/pd.407","article-title":"Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome","volume":"22","author":"Yaron","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2004.05.068_bib10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3109\/00016349509024379","article-title":"Human placental lactogen and pregnancy-associated plasma protein A in first trimester and subsequent fetal growth","volume":"74","author":"Pedersen","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2004.05.068_bib11","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/417916a","article-title":"Early pregnancy origins of low birth weight","volume":"417","author":"Smith","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2004.05.068_bib12","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1210\/jcem.87.4.8430","article-title":"Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2004.05.068_bib13","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1093\/oxfordjournals.humrep.a137965","article-title":"Reduced circulating placental protein concentrations during the first trimester are associated with preterm labor and low birth weight","volume":"8","author":"Johnson","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2004.05.068_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1097-0223(199802)18:2<147::AID-PD231>3.0.CO;2-W","article-title":"Maternal serum levels of free beta hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery","volume":"18","author":"Morssink","year":"1998","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2004.05.068_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000065384","article-title":"First trimester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome","volume":"17","author":"Yaron","year":"2002","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2004.05.068_bib16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/1097-0223(200006)20:6<495::AID-PD846>3.0.CO;2-U","article-title":"Screening for triploidy by fetal nuchal translucency and maternal serum free beta hCG and PAPP-A at 10-14 weeks of gestation","volume":"20","author":"Spencer","year":"2000","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2004.05.068_bib17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/pd.420","article-title":"A first trimester trisomy 13\/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta hCG and PAPP-A","volume":"22","author":"Spencer","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2004.05.068_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1097-0223(199902)19:2<175::AID-PD524>3.0.CO;2-4","article-title":"First trimester non-invasive prenatal diagnosis of triploidy","volume":"19","author":"De Graaf","year":"1999","journal-title":"Prenat Diagn"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937804005538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937804005538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:45:28Z","timestamp":1757583928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937804005538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0002937804005538"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2004.05.068","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of extreme first-trimester free human chorionic gonadotropin-\u03b2, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2004.05.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}